and 15 apparently healthy subjects (C) were enrolled into the study. The underlying kidney diseases in HD patients were: chronic glomerulonephritis (40%), chronic inter stitial nephritis (23%), polycystic kidney disease (8%), hypertensive nephropathy (8%), and those of unknown origin (21%). All HD-DM patients were on insulin therapy. Study protocol was approved by Bioethics Committee of the Medical University of Silesia in Katowice. Characteristics of study groups are given in TAbLE 1. All hemo dialysed subjects were recruited from the Dialysis Unit of Silesian Hospital in Cieszyn. Exclusion criteria were as follows: a past or present history of organic gastric and/ or duodenal disorders (diagnosed during panendoscopy), liver and bile duct disease, a history of abdominal surgery (except appendectomy), poor glycemic control, acute infections, pregnancy or lactation. All subjects were asked to discontinue prokinetic drugs or proton pump inhibitors at least 2 weeks prior to the study.
In all subjects blood samples were drawn while fasting and at 30, 60 and 120 min after ingestion of a test meal. The standard test breakfast consisted of: 40 g corn flakes, 250 ml milk, 100 ml fresh grapefruit juice and 5 g sugar (14.4% protein, 12.0% fat, 73.6% carbohydrate; caloric value of 370 kcal [1545 kJ]), and additionally contained 1 g of para cetamol. In all hemo dialysis patients study procedures were performed before hemo dialysis sessions. Plasma ghrelin, growth hormone, insulin, and glucose were measured in blood samples. Gastric emptying was assessed indirectly based on changes in serum para cetamol concentrations taken with the test meal. 17 Paracetamol absorption takes place in the small intestine but not in associated with increased mortality in this group of patients in comparison to the general population. 12 The pathogenesis of diabetic gastroparesis has not been fully established. There is a view that impaired gastric emptying, among others, is a consequence of sympathetic nervous system dysfunction (diabetic neuropathy), ischemic degeneration of the smooth muscle cells of the gastrointestinal tract, and hormonal changes (increased serum motilin and cholecystokinin). 13 Similarly to diabetic patients, delayed gastric emptying is a common finding in hemo dialysis patients (uremic gastroparesis). 14 To date, the role of ghrelin in the pathogenesis of uremic gastroparesis has not been investigated. Recently, Murray et al. have Abbreviations: C - control, HD - hemodialysis patients with nondiabetic nephropathies, HDDM - hemodialysis patients with diabetic nephropathy group; however, these differences were not statistically significant. Moreover, the HD-DM group had the highest body mass index (BMI) (TAbLE 1).
In both groups of hemo dialysis patients (HD and HD-DM patients) plasma ghrelin concentrations were similar, 49% and 33% higher than in C, respectively (TAbLE 1) . The adjustment for age did not markedly change ghrelin values (HD 6.3 ±1.8; HD-DM 5.7 ±2.0; C 4.3 ±1.6 ng/ml). As expected, mean serum glucose levels were higher in hemo dialiysis patients with diabetes (significantly compared to C alone). Fasting plasma levels of growth hormone were higher in hemo dialysis patients (significantly in the HD group alone) when compared to C. Intake of the test meal (equivalent of standard breakfast) was followed by a decline in plasma ghrelin levels, most evident at 60 min, 7.3, 5.4 and 6.7% in C, HD and HD-DM patients, respectively (TAbLE 2, FIGuRE). In all groups a reduction in plasma ghrelin levels 60 min after ingestion in comparison to the initial values was observed (significant in HD-DM and C). Suppression of ghrelin secretion persisted longer (over 120 min after ingestion) in both groups of hemo dialysis patients, significant only in HD-DM. After 120 min ghrelinemia reached the baseline values only in C.
A postprandial increase of insulin secretion at 30 min was significantly higher in C when compared to both groups of hemo dialysis patients (TAbLE 2, FIGuRE) . The highest postprandial insulinemia in hemo dialysis patients was delayed and was observed 60 min after ingestion of the test meal. A postprandial increase in insulin secretion lasted even 120 min after meal ingestion. Only in C the stomach, therefore measurement of its serum concentration allows to assess gastric emptying. Serum para cetamol concentrations were measured in the blood samples withdrawn at the previously mentioned time points (at 30, 60 and 120 min after ingestion of a test meal), and additionally 15 min after intake of the test breakfast.
In thawed plasma samples total ghrelin (Ghrelin Ria Kit, Linco Research Inc., USA) and growth hormone levels (BioSource hGH-IRMA, BioSource Europe S.A., Belgium) were measured using radioimmunoassay. Serum insulin (Elecsys, Roche Diagnostics GmbH, Germany) and serum para cetamol levels (AxSYM Paracetamol, Abbott Laboratories Diagnostic Division, USA) were measured using an enzyme-linked immunosorbent assay. Serum glucose in venous blood was determined directly after drawing by a routine enzymatic method in the hospital laboratory.
In all subjects total fat mass was assessed by dual-energy X-ray absorptiometry (DEXA) using a Lunar DPX-L (Lunar Radiation Corporation, USA).
Statistical analysis was performed using Statistica 6.0 software showing results as mean values and 95% confidence inter val. The inter group differences were calculated using the Mann-Whitney U test. The Spearman test was used to assess correlations between variables. A p <0.05 was considered statistically significant.
REsuLTs Both groups of hemo dialysis patients were about 20 years older than C (TAbLE 1). There was an overrepresentation of males in HD group and overrepresentation of females in HD-DM In the present study fasting plasma ghrelin correlated significantly both with BMI (R = -0.390; p = 0.03) and total fat mass (R = -0.488; p = 0.006) in the combined group of hemo dialysis patients (HD + HD-DM). In C, the correlation between fasting plasma ghrelin and BMI alone was close to the level of statistical significance (R = -0.497; p = 0.06). Moreover, there was a significant inverse association between fasting plasma ghrelin and serum insulin levels (R = -0.342; p = 0.05) in the combined hemo dialysis patients (HD + HD-DM). In C none of those correlations were significant. dIsCussION In the current study we have confirmed previous findings showing that plasma ghrelin levels are elevated in patients with chronic renal failure. 7, 8, 9 Moreover, results of these studies suggest that the kidneys are an important site for bio degradation/elimination of circulating ghrelin. The values of plasma ghrelin levels obtained in our study were similar to those reported by Iglesias et al. 9 Lower values of plasma ghrelin levels were found by 8 These discrepancies may derive from different methods used for hormone assessment. Moreover, both groups of hemo dialysis patients were about 20 years older than the control group. As a plasma ghrelin concentration is decreasing with age, the age difference may in part contribute to a smaller difference in plasma ghrelin levels between hemo dialysis patients and the control group than expected.
Ghrelin is an anabolic hormone, thus hyperghrelinemia in patients with chronic kidney disease appears to be inconsistent with proteinthe peak of insulin secretion preceded maximum decrease in plasma ghrelin levels.
Plasma growth hormone levels in both groups of hemodialysis patients were higher than in C, significantly only in the HD group. In all study groups postprandial decrease of plasma growth hormone levels was detected at 30 and 60 min, the most pronounced and statistically significant at 60 min in the HD group.
At 15 min after ingestion serum para cetamol concentrations were comparable in all groups. An increase in mean serum para cetamol at subsequent time points was observed until 60 min in C and HD groups, and until 120 min in the HD-DM group (TAbLE 2, FIGuRE) . In individual profile analysis of serum para cetamol concentrations, 50% of HD-DM and only 31% of HD patients achieved the peak concentration at 120 min. In HD-DM patients with delayed para cetamol absorption, there was a more pronounced decline (compared to the baseline values) in plasma ghrelin levels 120 min after ingestion (n = 8) compared to HD-DM patients with normal absorption (n = 8) [(-8.4 , 95% CI from -13.2 to -3.6% vs. -5.5, 95% CI from -11.5 to 0.6%, respectively; p = NS].
A significant inverse correlation was found between the value of postprandial plasma ghrelin decline at 60 min and serum para cetamol concentrations in C (R = -0.676, p = 0.001). A similar correlation at 120 min in this group did not reach the statistical significance (R = -0.462, p = 0.11). No correlation was observed between a reduction in postprandial plasma ghrelin at 60 and 120 min and the corresponding concentrations of serum para cetamol in both hemo dialysis groups, also in combined analyses (HD + HD-DM). healthy subjects) do not allow us to establish mechanisms of ghrelin suppression. The limitation of our study is the lack of assessment of the degree of auto nomic neuropathy that could have an important influence on gastric emptying in patients with gastroparesis.
In conclusion, plasma ghrelin levels in hemodialysis patients are significantly higher than in healthy subjects, suggesting disturbed ghrelin biodegradation in uremic patients. Prolonged postprandial suppression of ghrelin secretion may contribute to the pathogenesis of gastric emptying disorders in hemo dialysis patients, especially in those with diabetic nephropathy.
-calorie malnutrition, which is a common finding in uremic patients. The incidence of proteincalorie malnutrition varies from 10 to 70% of hemo dialysis patients 18,19 and contributes to increased morbidity and mortality rates in this population. 12 Diminished bio logical activity of ghrelin in patients with chronic kidney disease may be caused predominantly by an increased concentration of desacyl ghrelin, an inactive fraction of total ghrelin in this population. 7 Another explanation might be increased receptor or postreceptor resistance to endogenous ghrelin action on target organs in patients with chronic kidney disease.
Circulating ghrelin levels have been reported to decrease after meal ingestion. The decrease in postprandial plasma ghrelin concentrations demonstrated in our study indicates that physio logical mechanisms of ghrelin secretion after food stimuli are preserved in hemo dialysis patients. However, there were considerable differences in postprandial changes in plasma ghrelin levels between hemo dialysis patients and healthy subjects: decreased plasma ghrelin levels persisted longer (over 120 min after ingestion of a test meal) in both groups of hemo dialysis patients (significant only in hemo dialysis patients with diabetic nephropathy), while in healthy subjects ghrelinemia returned to the initial values at 120 min. This delayed suppression of ghrelin secretion after ingestion of a test meal may lead to the development of impaired gastric emptying (gastroparesis) in hemo dialysis patients, particularly in those with diabetic nephropathy. The possible participation of disturbed ghrelin secretion in the pathogenesis of diabetic gastroparesis had been previously shown by Asai et al. who demonstrated the lack of ghrelin response to oral glucose in patients with diabetic gastroparesis and normal kidney function. 16 Impaired gastric emptying is observed even in 50% of diabetic patients. 11 Diabetic gastroparesis can be followed by a variety of meta bolic complications: poor glycemic control, frequent episodes of postprandial hypoglycemia and, in advanced stage patients, with feeding difficulties and vomiting leading to the development of protein-calorie malnutrition. Prokinetic activity of ghrelin after parenteral administration has been already demonstrated both in animal models and in humans.
15,20 Therefore, ghrelin receptor agonists are a potential prokinetic agent for treatment of gastroparesis and protein-calorie malnutrition.
Plasma ghrelin concentration is inversely related to body mass. Low plasma ghrelin levels are found in obese subjects, whereas in anorectic patients they are markedly higher.
21 The present study demonstrates an inverse correlation between fasting ghrelinemia and BMI, total fat mass and serum insulin concentration in hemodialysis patients. Thus, our results confirm previous findings, suggesting preserved physio logical mechanisms of ghrelin secretion in hemo dialysis patients. The above mentioned relationships, as well as the inverse correlation between serum para cetamol concentration and decline in plasma ghrelin levels at 60 min postprandially (in
